When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Acceleron Shares Surge as Its Hypertension Drug Meets Trial Endpoints
Acceleron Pharma Inc.
Shares of Acceleron Pharma (NASDAQ: XLRN) shot up significantly in after-hours trading on Monday when the company announced positive results for its drug to treat pulmonary arterial hypertension (PAH). A phase 2 clinical trial of Acceleron's drug candidate, sotatercept, met both the primary and secondary endpoints of the trial.
More specifically, the study in question found that there was a significant reduction in pulmonary vascular resistance, the amount of blood pressure in the arteries that provide blood to the lungs, in comparison to the placebo.